Ahmed Farhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmed Farhan has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Clifford R. Weiss
Johns Hopkins University School of Medicine
2 shared publications Frank Yuan
Division of Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland https://twitter.com/DrFrankYuan
2 shared publications- Adham Khalil
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, United States
1 shared publication Anna Gong
The Johns Hopkins University School of Medicine, Baltimore, Maryland
1 shared publication- Christopher Do Bailey
Department of Vascular and Interventional Radiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
1 shared publication Christopher R. Bailey
Division of Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland
1 shared publication
Latest Publications
- 15 May 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (9) , 1609-1617.e2
Intraoperative Neuromonitoring during Peripheral Arteriovenous Malformation Embolization
- 15 May 2023
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 34 (9) , 1609-1617.e2
Intraoperative Neuromonitoring during Peripheral Arteriovenous Malformation Embolization
- 28 June 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (7) , 841-844
Clinical Outcomes following Percutaneous Urinary Diversion for Hemorrhagic Cystitis
- 28 June 2022
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 33 (7) , 841-844
Clinical Outcomes following Percutaneous Urinary Diversion for Hemorrhagic Cystitis
- 5 October 2021
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (1) , 199-209
Clinical manifestations of patients with GDF2 mutations associated with hereditary hemorrhagic telangiectasia type 5
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant fibrovascular dysplasia caused by mutations in ENG, ACVRL1, and SMAD4. Increasingly, there has been an appreciation for vascular conditions with phenotypic overlap to HHT but which have distinct clinical manifestations and arise from novel or uncharacterized gene variants. This study reported on a cohort of four unrelated probands who were diagnosed with a rare form of GDF2‐related HHT5, for which only five prior cases have been described. Two patients harbored heterozygous missense variants not previously annotated as pathogenic (p.Val403Ile; p.Glu355Gln). Clinically, these patients had features resembling HHT1, including cerebrovascular involvement of their disease (first report documenting cerebral involvement of HHT5), but with earlier onset of epistaxis and a unique anatomic distribution of dermal capillary lesions that involved the upper forelimbs, trunk, and head. The other two patients harbored interstitial deletions larger than five megabases between 10q11.22 and 10q11.23 that included GDF2. To our knowledge, this is the first report detailing large genomic deletions leading to HHT5. These patients also demonstrated mucocutaneous capillary dysplasias, including intranasal vascular lesions complicated by childhood‐onset epistasis, with a number of extravascular findings related to their 10q11.21q11.23 deletion. In conclusion, patients with GDF2‐related HHT may present with a number of unique characteristics that differ from classically reported features of HHT.
- 5 October 2021
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (1) , 199-209
Clinical manifestations of patients with GDF2 mutations associated with hereditary hemorrhagic telangiectasia type 5
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant fibrovascular dysplasia caused by mutations in ENG, ACVRL1, and SMAD4. Increasingly, there has been an appreciation for vascular conditions with phenotypic overlap to HHT but which have distinct clinical manifestations and arise from novel or uncharacterized gene variants. This study reported on a cohort of four unrelated probands who were diagnosed with a rare form of GDF2‐related HHT5, for which only five prior cases have been described. Two patients harbored heterozygous missense variants not previously annotated as pathogenic (p.Val403Ile; p.Glu355Gln). Clinically, these patients had features resembling HHT1, including cerebrovascular involvement of their disease (first report documenting cerebral involvement of HHT5), but with earlier onset of epistaxis and a unique anatomic distribution of dermal capillary lesions that involved the upper forelimbs, trunk, and head. The other two patients harbored interstitial deletions larger than five megabases between 10q11.22 and 10q11.23 that included GDF2. To our knowledge, this is the first report detailing large genomic deletions leading to HHT5. These patients also demonstrated mucocutaneous capillary dysplasias, including intranasal vascular lesions complicated by childhood‐onset epistasis, with a number of extravascular findings related to their 10q11.21q11.23 deletion. In conclusion, patients with GDF2‐related HHT may present with a number of unique characteristics that differ from classically reported features of HHT.